Disease Info Card

Childhood Soft Tissue Sarcoma

Information about Childhood Soft Tissue Sarcoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Childhood Soft Tissue Sarcoma

Most recent studies have shown that Childhood Soft Tissue Sarcoma shares some biological mechanisms with alveolar-rhabdomyosarcoma, bone-neoplasms, carcinoma, cell-transformation-neoplastic, ewings-sarcoma-primitive-neuroectodermal-tumor-(pnet), li-fraumeni-syndrome, malignant-neoplasm-of-breast, malignant-neoplasms, malignant-paraganglionic-neoplasm, malignant-peripheral-nerve-sheath-tumor, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, neoplasms-second-primary, rhabdomyosarcoma, rhabdomyosarcoma-embryonal, sarcoma, soft-tissue-neoplasms, steroid-sulfatase-deficiency-disease, synovial-sarcoma.

Among the many pathways, these few ones have gauged particular interests from scientists studying Childhood Soft Tissue Sarcoma, and have been seen in publications frequently: Cell Adhesion, Cell Cycle, Methylation

Quite a number of genes have been found to play important roles in Childhood Soft Tissue Sarcoma, such as BMP4, CDKN1A, CRP, EFS, FOXO1, GATA3, KIDINS220, MID1, PARP1, PAX3, RB1, SMN1, SNRPN, STMN1, STS, TGM1, TP53. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.